We have been shortlisted in the top 10 startups in the sustainability track!
Eager to share to the world on the amazing potential cannabinoids may bring to our wellness!
Come and join us!
You can access the webcast by clicking here.
Today: 🇪🇺 Commission webinar with experts from Member States & sector organisations dedicated to industrial #hemp.— EU Agriculture🌱 (@EUAgri) April 26, 2021
Participants will discuss the market for hemp-derived products & opportunities to further develop the sector.
📽️ Live from 14:30 CEST ↓https://t.co/Vrt5Mty7Zq pic.twitter.com/3LFz38Inux
✳️ We presented the recent Assemblée nationale report on hemp regarding findings about THC level regulations across Europe to help with an overview of existing landscape
🌱 We are actively working to move in the direction of a greener future!
💄 In 2019 a new entry was included in the CosIng database for Cannabis sativa leaf extract however, the situation for using phytocannabinoid-rich extracts in cosmetics was not unambiguous, as an entry for “Cannabis sativa extract” and for “Canabinoids” still referenced to prohibition for use of cosmetics as narcotic drugs. Until now, the CosIng included only synthetically produced cannabidiol without restrictions. This contributed to a hesitance of manufacturers to incorporate cannabidiol (CBD) in cosmetics formulas.
✨ At the beginning of February 2021 the European Commission supplemented the CosIng database with a new entry for natural cannabidiol (derived from extract or tincture or resin of Cannabis) without restrictions for use in cosmetics.
🌿 Naturally extracted cannabidiol is made from an extract of Cannabis sativa. Cosmetic ingredients are qualified as chemical substances and subject to REACH and CLP regulations. According to the European Chemicals Agency Guidance for identification and naming of substances under REACH and CLP a mono-constituent substance is a substance where the main constituent is present at or above 80%. However, deviation from the "80% rule" is possible if the main constituent is <80% but the substance can be shown to have similar physico-chemical properties and the same hazard profile as other mono-constituent substances with the same identity. This would be a suitable approach for Cannabis sativa extracts which contain a number of chemically similar compounds (phytocannabinoids) in addition to the cannabidiol content. These concomitant substances exceeding 1% should be specified appropriately.
⚗️ From a safety perspective, the delta-9-tetrahydrocannabinol (the psychotropic substance) impurity levels in the substance should be specified irrespective of the concentration for purposes of toxicity assessment and to determine the compliance of the recipe and end product with target market local product safety rules. Additional controlled substance rules in each market must be considered as well.
🧪 We recognize that using synthetic ingredients would go against the values of many cosmetics manufacturers so this opens the door for developing many great cosmetic product lines incorporating natural cannabidiol!
🌱 Big thanks to the European Industrial Hemp Association for working with DG Sante to bring this change so early!
📯 Contact us if you have any questions relating to CBD cosmetic or wellness product development, we will help you!